Atlas Genetics elects Neil Butler chairman
This article was originally published in Clinica
Neil Butler has joined UK point-of-care diagnostics company Atlas Genetics as chairman of its board of directors. Mr Butler's most recent role was CEO of Vivacta, which also specialised in POC diagnostics. Prior to this, he led Oxford Biosensors, an Oxford University spin-out offering hand-held medical diagnostics. Atlas, based in Bath, raised £16.9m ($27.3m) in series B financing last year (www.clinica.co.uk, 21 July 2011); the capital will be used to accelerate the launch of Atlas's first two tests – one for chlamydia alone and the other for chlamydia and gonorrhoea – that run on its Velox ultra-rapid POC platform.